Search results
Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat...
Digital Journal· 3 days agoRevive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics and ...
Randomized trial, meta-analysis shed new light on optimal antibiotic strategy for sepsis
Center for Infectious Disease Research and Policy· 3 days agoTwo studies published yesterday in JAMA indicate that continuous infusions of beta-lactam...
Gacha Games Market Size to Grow USD 781.5 Million by 2030 at a CAGR of 8.5% | Valuates Reports
Benzinga· 23 hours agoBANGALORE, India, June 14, 2024 /PRNewswire/ -- Gacha Games Market is Segmented by Type (Card Games, RPG Games), by Application (Android, IOs). The Global Gacha Games market was valued at USD 452 Million in 2023 and is
Lung Cancer Screening Rates Remain Low in the U.S., Especially in the South
MedPage Today· 5 days agoFewer than one in five people eligible for lung cancer screening reported being up to date with...
Study show tirzepatide beneficial for resolution of MASH in patients with MASH, fibrosis
Medical Xpress· 2 days agoFor patients with metabolic dysfunction-associated steatohepatitis (MASH) and moderate-to-severe...
Axiom Real-Time Metrics Announces Leadership Transition
Morningstar· 3 days agoAxiom Real-Time Metrics Announces Leadership Transition Axiom Real-Time Metrics (“Axiom”), a premier provider of unified eClinical solutions and services that are used to enhance the efficiency of Phase I, II and III clinical trials and observational
Actinium Highlights Mutation Data from the Phase 3 SIERRA Trial of Iomab-B and Novel Linker...
KOLR - KSFX Ozarks· 5 days agoIomab-B led bone marrow transplant improved survival in patients with high-risk relapsed or refractory acute myeloid leukemia including those with a TP53 mutationIomab-B safely delivered radiation ...
ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and...
Benzinga· 5 days agoWINSTON-SALEM, N.C., June 10, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. PROK ("ProKidney"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD) ...
Hybrid working from home improves retention without damaging performance - Nature
Nature· 3 days agoIn July 2021, Trip.com decided to evaluate hybrid WFH after seeing its popularity amongst US tech firms. The first step took place on 27 July 2021, when the firm surveyed 1,612 eligible engineers ...
No one asks how new dads are doing. A pilot program aims to help
WBUR Boston· 4 days agoFor decades, federal surveys have tracked the health and habits of new mothers. Now, Democrats in...